| Literature DB >> 33673266 |
Nayara Sousa da Silva1, Nathália Kelly Araújo2, Alessandra Daniele-Silva3, Johny Wysllas de Freitas Oliveira4, Júlia Maria de Medeiros5, Renata Mendonça Araújo6, Leandro De Santis Ferreira2, Hugo Alexandre Oliveira Rocha7, Arnóbio Antônio Silva-Junior2, Marcelo Sousa Silva8,9, Matheus de Freitas Fernandes-Pedrosa2.
Abstract
The global rise of infectious disease outbreaks and the progression of microbial resistance reinforce the importance of researching new biomolecules. Obtained from the hydrolysis of chitosan, chitooligosaccharides (COSs) have demonstrated several biological properties, including antimicrobial, and greater advantage over chitosan due to their higher solubility and lower viscosity. Despite the evidence of the biotechnological potential of COSs, their effects on trypanosomatids are still scarce. The objectives of this study were the enzymatic production, characterization, and in vitro evaluation of the cytotoxic, antibacterial, antifungal, and antiparasitic effects of COSs. NMR and mass spectrometry analyses indicated the presence of a mixture with 81% deacetylated COS and acetylated hexamers. COSs demonstrated no evidence of cytotoxicity upon 2 mg/mL. In addition, COSs showed interesting activity against bacteria and yeasts and a time-dependent parasitic inhibition. Scanning electron microscopy images indicated a parasite aggregation ability of COSs. Thus, the broad biological effect of COSs makes them a promising molecule for the biomedical industry.Entities:
Keywords: antiprotozoal; chitooligosaccharides; neglected tropical disease
Mesh:
Substances:
Year: 2021 PMID: 33673266 PMCID: PMC7917997 DOI: 10.3390/md19020110
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118